DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Lurasidone Hydrochloride is a drug marketed by Accord Hlthcare, Amneal Pharms Co, Emcure Pharms Ltd, Invagen Pharms, Lupin Ltd, Sun Pharm, Teva Pharms Usa, Torrent, and Zydus Pharms. and is included in nine NDAs.
The generic ingredient in LURASIDONE HYDROCHLORIDE is lurasidone hydrochloride. There are twenty-six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the lurasidone hydrochloride profile page.
A generic version of LURASIDONE HYDROCHLORIDE was approved as lurasidone hydrochloride by ACCORD HLTHCARE on January 3rd, 2019.
Summary for LURASIDONE HYDROCHLORIDE
Recent Clinical Trials for LURASIDONE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
|Sumitomo Pharmaceutical (Suzhou) Co., Ltd.||Phase 3|
|Columbia University||Phase 4|
|New York State Psychiatric Institute||Phase 4|